Synlett 2011(8): 1081-1084  
DOI: 10.1055/s-0030-1259927
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Magnetically Recoverable Pd/Fe3O4-Catalyzed Hiyama Cross-Coupling of Aryl Bromides with Aryl Siloxanes

B. Sreedhar*, A. Suresh Kumar, Divya Yada
Inorganic and Physical Chemistry Division, Indian Institute of Chemical Technology (Council of Scientific and Industrial Research), Hyderabad 500007, India
Fax: +91(40)27160921; e-Mail: sreedharb@iict.res.in;
Weitere Informationen

Publikationsverlauf

Received 2 December 2010
Publikationsdatum:
29. März 2011 (online)

Abstract

This letter describes a simple and efficient method for the synthesis of biaryls by fluoride-free Hiyama cross-coupling of bromoarenes with aryl siloxanes using magnetically separable Pd/Fe3O4 as the catalyst under aqueous conditions. This methodology is applicable to wide range of aryl bromides and aryl siloxanes. High catalytic activity, ease of recovery using an external magnetic field and use of water as the solvent are additional eco-friendly attributes of this catalytic system. The catalyst was recycled five times without significant loss of catalytic activity.

    References and Notes

  • 1a Horton DA. Bourne GT. Smythe ML. Chem. Rev.  2003,  103:  893 
  • 1b Bringmann G. Gunther C. Ochse M. Schupp O. Tasler S. Biaryls in Nature: A Multi-Facetted Class of Stereochemically, Biosynthetically, and Pharma-cologically Intriguing Secondary Metabolites, In Progress in the Chemistry of Organic Natural Products   Vol. 82:  Herz W. Falk H. Kirby GW. Moore RE. Springer-Verlag; New York: 2001. 
  • 1c Hajduk PJ. Bures M. Praestgaard J. Fesik SW. J. Med. Chem.  2000,  43:  3443 
  • 1d Bemis GW. Murcko MA. J. Med. Chem.  1996,  39:  2887 
  • 2a Schmidt U. Leitenberger V. Griesser H. Schmidt J. Meyer R. Synthesis  1992,  1248 
  • 2b Schmidt U. Meyer R. Leitenberger V. Griesser H. Lieberknecht A. Synthesis  1992,  1025 
  • 3a Markham A. Goa KL. Drugs  1997,  54:  299 
  • 3b Croom KF. Keating GM. Am. J. Cardiovasc. Drugs  2004,  4:  395 
  • 3c Sharpe M. Jarvis B. Goa KL. Drugs  2001,  61:  1501 
  • 3d Yusuf S. Am. J. Cardiol.  2002,  89:  18A 
  • 4 Matheron ME. Porchas M. Plant Dis.  2004,  88:  665 
  • 5 Poetsch E. Kontakte  1988,  2:  15 
  • 6a Miyaura N. Yamada K. Suzuki A. Tetrahedron Lett.  1979,  3437 
  • 6b Stanforth SP. Tetrahedron  1998,  54:  263 
  • 6c Suzuki A. Pure Appl. Chem.  1991,  63:  419 
  • 6d Wolfe JP. Buchwald SP. Angew. Chem. Int. Ed.  1999,  38:  2413 
  • 6e Zapf A. Beller M. Chem. Eur. J.  2000,  6:  1830 
  • 6f Bedford RB. Cazin CSJ. Coles SJ. Gelbrich T. Horton PN. Hursthouse MB. Light ME. Organometallics  2003,  22:  987 
  • 7a Baba S. Negishi E. J. Am. Chem. Soc.  1976,  98:  6729 
  • 7b Dai C. Fu GC. J. Am. Chem. Soc.  2001,  123:  2719 
  • 8a Tamao K. Sumitani K. Kumada M. J. Am. Chem. Soc.  1972,  94:  4374 
  • 8b Herrmann WA. Bohm VPW. Reisinger C. J. Organomet. Chem.  1999,  576:  23 
  • 9a Hatanaka Y. Hiyama T. J. Org. Chem.  1988,  53:  920 
  • 9b Gouda K. Hagiwara E. Hatanaka Y. Hiyama T. J. Org. Chem.  1996,  61:  7232 
  • 9c Mowery ME. DeShong P. Org. Lett.  1999,  1:  2137 
  • 9d Lee J. Fu GC. J. Am. Chem. Soc.  2003,  125:  5616 
  • 9e Riggleman S. Deshong P. J. Org. Chem.  2003,  68:  8106 
  • 9f Lee HM. Nolan SP. Org. Lett.  2000,  2:  2053 
  • 10a Stille JK. Pure Appl. Chem.  1985,  57:  1771 
  • 10b Stille JK. Angew. Chem., Int. Ed. Engl.  1986,  25:  508 
  • 10c Farina V. Krishnamurthy V. Scott WJ. Org. React. (N.Y.)  1997,  50:  1 
  • 10d Hassa J. Svignon M. Gozzi C. Schulz E. Lemaire M. Chem. Rev.  2002,  102:  1359 
  • 10e Littke AF. Fu GC. Angew. Chem. Int. Ed.  2002,  41:  4176 
  • 11a Hagiwara E. Gouda K. Hatanaka Y. Hiyama T. Tetrahedron Lett.  1997,  38:  439 
  • 11b Murata M. Shimazaki R. Watanabe S. Masuda Y. Synthesis  2001,  2231 
  • 12a Wolf C. Lerebours R. Org. Lett.  2004,  6:  1147 
  • 12b Gordillo A. Jesus E. Lopez-Mardomingo C. Org. Lett.  2006,  8:  3517 
  • 13a Shi S. Zhang Y. J. Org. Chem.  2007,  72:  5927 
  • 13b Ranu BC. Dey R. Chattopadhyay K. Tetrahedron Lett.  2008,  49:  3430 
  • 13c Huang T. Li CJ. Tetrahedron Lett.  2002,  43:  403 
  • 13d Srimani D. Sawoo S. Sarkar A. Org. Lett.  2007,  9:  3639 
  • 13e Alacid E. Najera C. Adv. Synth. Catal.  2006,  348:  945 
  • 13f Alacid E. Najera C. Adv. Synth. Catal.  2006,  348:  2085 
  • 14a Yavuz CT. Mayo JT. Yu WW. Prakash A. Falkner JC. Yean S. Cong LL. Shipley HJ. Kan A. Tomson M. Natelson D. Colvin VL. Science  2006,  314:  964 
  • 14b Sun SH. Murray CB. Weller D. Folks L. Moser A. Science  2000,  287:  1989 
  • 14c Gao J. Zhang W. Huang P. Zhang B. Zhang X. Xu B. J. Am. Chem. Soc.  2008,  130:  3710 
  • 14d Lu J. Yang SH. Ng KM. Su CH. Yeh CS. Wu YN. Shieh DB. Nanotechnology  2006,  17:  5812 
  • 14e Li Z. Wei L. Gao M. Lei H. Adv. Mater. (Weinheim, Ger.)  2005,  17:  1001 
  • 14f Yu MK. Jeong YY. Park J. Park S. Kim JW. Min JJ. Kim K. Jon S. Angew. Chem. Int. Ed.  2008,  47:  5362 
  • 15a Roca AG. Morales MP. O’Grady K. Serna CJ. Nanotechnology  2006,  17:  783 
  • 15b Zheng YH. Cheng Y. Bao F. Wang YS. Mater. Res. Bull.  2006,  41:  525 
  • 15c Lang C. Schueler D. Faivre D. Macromol. Biosci.  2007,  7:  144 
  • 15d Majewski P. Thierry B. Crit. Rev. Solid State Mater. Sci.  2007,  32:  203 
  • 16 Sreedhar B. Kumar AS. Reddy PS. Tetrahedron Lett.  2010,  51:  1891 
  • 17 Liu J. Peng X. Sun W. Zhao Y. Xia C. Org. Lett.  2008,  10:  3933 
  • 18 Metal Catalyzed Cross-Coupling Reactions   Diederich F. de Mejiere A. John Wiley & Sons; New York: 2004. 
19

Synthesis of the Fe 3 O 4 nanoparticles: FeSO4˙7H2O (13.9 g) and Fe2 (SO4)3 (20 g) were dissolved in H2O (500 mL) in a 1000 mL beaker. NH4OH (aq, 25%) was added slowly to adjust the pH of the solution to 10. The reaction mixture was then continually stirred for 1 h at 60 ˚C. The precipitated nanoparticles were separated magnetically, washed with water until the pH 7, and then dried under vacuum at 60 ˚C for 2 h. This magnetic nano ferrite (Fe3O4) was then used for the preparation of Pd/Fe3O4.
Synthesis of the Pd/Fe 3 O 4 catalyst: Fe3O4 nanoparticles were impregnated with Na2PdCl4 (1.0%) aqueous solution and stirred for 1 h. After impregnation, the suspension was adjusted to pH 12 by adding NaOH (1 M) and stirred for 6 h. The solid was washed with distilled H2O. The catalyst precursors were reduced by adding 0.2 M NaBH4 solution dropwise under gentle stirring in an ice-water bath for 30 min until no obvious bubbles were observed in the solution. The resulting Pd/Fe3O4 was washed thoroughly with distilled H2O and subsequently with EtOH. The palladium content in the catalyst was measured as 0.023 mmol˙g using ICP-AES.
General procedure for the Hiyama reaction: A mixture
of aryl bromide (1 mmol), aryl siloxane (1.2 mmol), NaOH (3 mmol), Pd/Fe3O4 catalyst (50 mg, 0.2 mol% of Pd) and distilled H2O (3 mL) was taken in a round-bottomed flask and stirred at 90 ˚C for 6 h. After completion of the reaction (monitored by TLC) the catalyst was easily separated from the reaction mixture with an external magnet. After removing the solvent, the crude material was purified by chromatography on silica gel to afford the pure product. The spectroscopic data of all known compounds were identical to those reported in the literature. 2′-Methoxy-4-methylbiphenyl (Table  [²] , entry 8): ¹H NMR (300 MHz, CDCl3): δ = 2.35 (s, 3 H), 3.78 (s, 3 H), 6.88-6.99 (m, 2 H), 7.22-7.28 (m, 2 H), 7.15 (d, J = 8.0 Hz, 2 H), 7.35 (d, J = 8.0 Hz, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 21.1, 55.4, 111.1, 120.7, 128.3, 128.6, 129.3, 130.7, 131.4, 131.5, 136.4, 156.4. MS (EI): m/z = 198 [M]+. 4′-Methoxy-2,4,6-trimethylbiphenyl (Table  [²] , entry 16): ¹H NMR (300 MHz, CDCl3): δ = 2.03 (s, 6 H), 2.35 (s, 3 H), 3.86 (s, 3 H), 6.95 (s, 2 H), 7.07 (d, J = 8.6 Hz, 2 H), 7.49 (d, J = 8.6 Hz, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 20.7, 20.9, 55.2, 113.7, 127.9, 130.3, 133.2, 136.4, 138.6, 158.1. MS (EI): m/z = 226 [M]+. 4′-tert-Butyl-2,4,6-trimethylbiphenyl (Table  [²] , entry 17): ¹H NMR (300 MHz, CDCl3): δ = 1.39 (s, 9 H), 1.98 (s, 6 H), 2.30 (s, 3 H), 6.85 (s, 2 H), 7.01 (d, J = 8.3 Hz, 2 H), 7.41 (d, J = 8.3 Hz, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 20.8, 27.0, 31.3, 34.4, 125.6, 126.6, 127.9, 128.8, 136.2, 138.2, 149.8. MS (EI): m/z = 252 [M]+. 1-p-Tolylnaphthalene (Table  [²] , entry 18): ¹H NMR (300 MHz, CDCl3): δ = 2.45 (s, 3 H), 7.25 (d, J = 8.3 Hz, 2 H), 7.33-7.38 (m, 3 H), 7.39-7.49 (m, 3 H), 7.77-7.92 (m, 3 H). ¹³C NMR (75 MHz, CDCl3): δ = 21.2, 125.3, 125.6, 125.8, 126.0, 126.8, 127.4, 128.2, 128.9, 129.9, 131.6, 133.7, 136.8, 137.7, 140.2. MS (ESI): m/z = 218 [M]+.